Core Viewpoint - MEDIROM MOTHER Labs Inc. has approved a private placement of new shares to its management team as part of its Series A financing round, valuing the company at JPY 9 billion, with funding expected by the end of October [1] Group 1: Company Background - MOTHER Labs operates as the health tech division within the MEDIROM Group, focusing on health guidance programs through the "Lav" healthcare app and the development of wearable devices [2][10] - The decision to conduct a capital increase aims to enhance rapid decision-making and management structure, with the management team investing to boost business responsibility and growth motivation [2] Group 2: Future Outlook - The capital increase will strengthen MOTHER Labs' capital base, facilitating the development of an upgraded version of the MOTHER Bracelet and establishing systems for product market entry [3] - The MEDIROM Group aims to create new value in the healthcare and wellness sector, driving business growth both domestically and internationally [3]

Core Viewpoint - MEDIROM Healthcare Technologies Inc. has announced that its "REMONY for Driver" remote health management system has been certified by Japan's Ministry of Land, Infrastructure, Transport and Tourism as a device for preventing fatigue-related driving [2][4]. Group 1: Product Overview - "REMONY for Driver" utilizes the MOTHER Bracelet, a 24/7 wearable device that monitors drivers' health and alertness, featuring a proprietary sleep assessment function [3][11]. - The MOTHER Bracelet is the world's first recharge-free smart tracker, generating power from temperature differences, thus eliminating data loss during recharging [11][14]. - The system allows for real-time health monitoring and trend analysis, which can help prevent health-related accidents [3][14]. Group 2: Subsidy Program - The "REMONY for Driver" system is eligible for a subsidy covering 50% of the equipment acquisition cost, with a general cap of 800,000 yen per business operator [4][5]. - The Ministry of Land, Infrastructure, Transport and Tourism allocated approximately 1.3 billion yen in subsidies in the previous fiscal year, with a similar budget expected for the current fiscal year [4]. Group 3: Future Outlook - The company aims to enhance system functionality and promote safe driving practices, focusing on preventing fatigue-related driving in the transportation industry [8]. - Future initiatives include conducting safety check-in operations based on health data and improving driver health and workplace environments [7][8].

Core Insights - MEDIROM Healthcare Technologies Inc. announced a second investment by Yasuhiro Hayami, Chief Business Officer of MEDIROM Mother Labs Inc., in the Series A financing at a pre-money valuation of JPY9 billion (approximately US$60 million) [1] - This investment follows Mr. Hayami's initial investment in December 2024, indicating his commitment to the company's growth potential and alignment with MEDIROM's corporate philosophy [1] Company Overview - MEDIROM Mother Labs Inc. is a subsidiary of MEDIROM Healthcare Technologies Inc., focusing on the health-tech sector [6] - The company offers the "Specific Health Guidance Program" through the "Lav" health application and has developed the 24/7 recharge-free MOTHER Bracelet, which is a smart tracker [6][8] - The MOTHER Bracelet utilizes innovative technology to generate power based on temperature differences, allowing it to operate without recharging and recording key health metrics [8][9] Executive Background - Yasuhiro Hayami has a diverse career, including roles as Executive Officer at transcosmos inc. and founder of Wise, Inc., before becoming the Chief Business Officer of MEDIROM Mother Labs in 2024 [2][6]